- Home
- CDIO vs ALBT Comparison
CDIO vs ALBT Comparison
Compare CDIO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- ALBT
- Stock Information
- Founded
- CDIO 2017
- ALBT 2014
- Country
- CDIO United States
- ALBT United States
- Employees
- CDIO N/A
- ALBT N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CDIO Health Care
- ALBT Health Care
- Exchange
- CDIO Nasdaq
- ALBT Nasdaq
- Market Cap
- CDIO 6.4M
- ALBT 7.4M
- IPO Year
- CDIO N/A
- ALBT N/A
- Fundamental
- Price
- CDIO $3.63
- ALBT $2.28
- Analyst Decision
- CDIO Buy
- ALBT
- Analyst Count
- CDIO 1
- ALBT 0
- Target Price
- CDIO $60.00
- ALBT N/A
- AVG Volume (30 Days)
- CDIO 41.9K
- ALBT 1.4M
- Earning Date
- CDIO 08-14-2025
- ALBT 08-26-2025
- Dividend Yield
- CDIO N/A
- ALBT N/A
- EPS Growth
- CDIO N/A
- ALBT N/A
- EPS
- CDIO N/A
- ALBT N/A
- Revenue
- CDIO $19,507.00
- ALBT $1,159,091.00
- Revenue This Year
- CDIO $1,434.82
- ALBT N/A
- Revenue Next Year
- CDIO $4,661.91
- ALBT N/A
- P/E Ratio
- CDIO N/A
- ALBT N/A
- Revenue Growth
- CDIO N/A
- ALBT N/A
- 52 Week Low
- CDIO $3.22
- ALBT $1.87
- 52 Week High
- CDIO $53.10
- ALBT $11.66
- Technical
- Relative Strength Index (RSI)
- CDIO 41.96
- ALBT 46.85
- Support Level
- CDIO $3.58
- ALBT $2.17
- Resistance Level
- CDIO $4.05
- ALBT $2.27
- Average True Range (ATR)
- CDIO 0.33
- ALBT 0.20
- MACD
- CDIO -0.01
- ALBT 0.02
- Stochastic Oscillator
- CDIO 24.74
- ALBT 53.25
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.